The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
HORIBA Medical is a renowned specialist in the design and manufacture of automated in-vitro diagnostic systems for analysis in haematology, clinical chemistry, and haemostasis. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management...
37th European Congress of Pathology
ACV, Vienna, Austria
6 -10 September, 2025
IBMS Congress
The International Convention Centre (ICC), Birmingham
22-25 September, 2025
IHC applications in laboratory practice webinar
Online
11-13 November, 2025
Transmission electron microscopy webinar
Online
25 November, 2025
Introduction to bone marrow trephine
Online
9 December, 2025